P01848 (TRAC_HUMAN) Homo sapiens (Human)

T cell receptor alpha chain constant UniProtKBInterProInteractive Modelling

140 aa; Sequence (Fasta)

Available Structures

136 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Cryo-EM structure of a membrane protein(CS) Heteromer
A0A0B4J271; A0A0K0K1A5; A0N4Z6; P04234; P07766; P09693; P0DSE2; P20963;
1-140
C3S;
Assess
Cryo-EM structure of a membrane protein(WT) Heteromer
A0A0B4J271; A0A0K0K1A5; A0N4Z6; P04234; P07766; P09693; P0DSE2; P20963;
1-140
CLR;
Assess
Cryo-EM structure of a membrane protein(LL) Heteromer
A0A0B4J271; A0A0K0K1A5; A0N4Z6; P04234; P07766; P09693; P0DSE2; P20963;
1-140
CLR;
Assess
Structure of human T cell receptor-CD3 complex Heteromer
A0A0B4J271; A0A0K0K1A5; A0N4Z6; P04234; P07766; P09693; P0DSE2; P20963;
1-140
Assess
The crystal structure of TCR DMF5 Heteromer
1-91
LI;GOL;
Assess
Crystal structure of JKA6 TCR Heteromer
A0A075B6T6; A0A5B6; P01850;
1-91
Assess
Crystal Structures of High Affinity Human T-Cell Receptors Bound to pMHC RevealNative Diagonal Bind… Heteromer
1-91
SO4;PG4;PGE;
Assess
Crystal structure of staphylococcal enterotoxin E in complex with a T cell receptor Heteromer
A0A0B4J277; A0A5A3; A0A5B9; P12993;
1-91
ZN;
Assess
Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances af… Heteromer
P01850; P04439; P61769; P78358;
1-91
Assess
Structure of mouse Va14Vb8.2NKT TCR-mouse CD1d-a-C-Galactosylceramide complex Heteromer
P01850; P01887; P11609;
1-91
NAG;QUX;NAG;
Assess
Crystal Structure of the DM1 TCR in complex with HLA-B*4405 and decamer EBV antigen Heteromer
P01889; P03204; P61769;
1-91
Assess
T cell receptor (TRAV22,TRBV7-9) structure Heteromer
A0A0B4J277; A0A5A3; A0A5B9;
1-90
GOL;
Assess
Crystal structure of human TCR Alpha Chain-TRAV21-TRAJ8 and Beta Chain-TRBV7-8 Heteromer
A0A0B4J279; A0A5B9;
1-90
Assess
A structural basis for immunodominant human T-cell receptor recognition. Heteromer
P01850; P04439; P61769;
1-90
Assess
Crystal Structure of clone18 TCR Heteromer
P01850;
1-90
Assess
High Affinity alpha24-beta17 T Cell Receptor for A2 HLA-Melanoma peptide complex Heteromer
P01850;
1-90
EDO;GOL;SO4;
Assess
Crystal structure of the 2B4 TCR Heteromer
1-90
Assess
Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr… Heteromer
P01850; P61769; Q3KSU1; Q8WLS4;
1-90
11×GOL;SO4;MES;
Assess
Crystal structure of the 2B4 TCR in complex with MCC/I-Ek Heteromer
P00039; P04224; P04230;
1-90
NAG;FUC;PEG;BMA;
Assess
Ternary crystal structure of the NKT TCR-CD1d-alpha-galactosylceramide analogue-OCH Heteromer
P01850; P01887; P11609;
1-90
NAG;PEG;NAG;FEE;D12;
Assess
Ternary crystal structure of the mouse NKT TCR-CD1d-4'deoxy-alpha-galactosylceramide Heteromer
P01850; P01887; P11609;
1-90
NAG;NAG;4GH;PEG;
Assess
Crystal structure of the 5F TCR in complex with HLA-DP4-Ply Heteromer
P01850; P04440; P20036; Q04IN8;
1-90
NAG;NAG;EDO;
Assess
Crystal structure of mouse CD1d-alpha-galactosylceramide with mouse Valpha14-Vbeta7 NKT TCR Heteromer
P01887; P11609;
1-90
NAG;NAG;AGH;
Assess
Crystal structure of the RL42 TCR unliganded Heteromer
1-90
Assess
Ternary crystal structure of the mouse NKT TCR-CD1d-C20:2 Heteromer
P01850; P01887; P11609;
1-90
NAG;DB3;
Assess
Ternary crystal structure of the mouse NKT TCR-CD1d-alpha-glucosylceramide(C20:2) Heteromer
P01850; P01887; P11609;
1-90
NAG;NAG;DB6;
Assess
Ternary crystal structure of the mouse NKT TCR-CD1d-3'deoxy-alpha-galactosylceramide Heteromer
P01850; P01887; P11609;
1-90
NAG;3GH;
Assess
Crystal structure of the RL42 TCR in complex with HLA-B8-FLR Heteromer
P01889; P61769; Q3KST2;
1-90
Assess
Crystal structure of staphylococcal enterotoxin A F47A mutant in complex with a T cell receptor Heteromer
A0A0B4J277; A0A5A3; A0A5B9; P0A0L2;
1-90
Assess
Structural and kinetic basis for heightened immunogenicity of T cell vaccines Heteromer
A0A0B4J279; A0A0K0K1A5; P01850;
1-89
Assess
Immune Receptor Heteromer
P01850;
1-89
Assess
Structural and kinetic basis for heightened immunogenicity of T cell vaccines Heteromer
A0A0B4J279; A0A0K0K1A5; P01850; P04439; P61769; P78358;
1-89
Assess
Structural and kinetic basis for heightened immunogenicity of T cell vaccines Heteromer
A0A0B4J279; A0A0K0K1A5; P01850; P04439; P61769; P78358;
1-89
Assess
Structural basis for recognition of mutant self by a tumor-specific, MHC class II-restricted TCR Heteromer
P01850;
1-89
Assess
1E6 TCR in complex with HLA-A02 carrying RQFGPDWIVA Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P04439; P61769;
1-89
15×EDO;PG4;SO4;GOL;
Assess
BK6 TCR apo structure Heteromer
P01850;
1-89
Assess
Crystal structure of the complex between human T cell receptor and staphylococcal enterotoxin Heteromer
P01850; P0A0M0;
1-89
GOL;NA;
Assess
Crystal Structure of CA5 TCR-HLA B*3505-LPEP complex Heteromer
C5MK56; P01850; P61769; Q3KSS8;
1-89
NA;IOD;
Assess
The complex between TCR DMF5 and human Class I MHC HLA-A2 with the bound MART-1(27-35) nonameric pe… Heteromer
P04439; P61769;
1-89
Assess
Crystal structure of the ternary complex between human T cell receptor, staphylococcal enterotoxin … Heteromer
P01850; P01903; P01911; P0A0M0; Q03909;
1-89
GOL;NA;
Assess
Crystal structure of TK3 TCR-HLA-B*35:08-HPVG complex Heteromer
C5MK56; P01850; P03211; P61769;
1-89
CL;NA;
Assess
Crystal structure of human TCR Alpha Chain-TRAV21-TRAJ8, Beta Chain-TRBV7-8, Antigen-presenting gly… Heteromer
A0A0B4J279; A0A5B9; P15813; P61769;
1-89
NAG;JLS;
Assess
Crystal structure of TK3 TCR-HLA-B*35:01-HPVG-Q5 complex Heteromer
C5MK56; P01850; P03211; P61769;
1-89
SO4;
Assess
Crystal structure of TK3 TCR-HLA-B*35:08-HPVG-D5 complex Heteromer
C5MK56; P01850; P61769; Q3KSS4;
1-89
Assess
Crystal Structure of SB27 TCR in complex with HLA-B*3508-13mer peptide Heteromer
P01850; P01889; P03206; P61769;
1-89
IOD;
Assess
Crystal Structure of the JM22 TCR in complex with HLA-A*0201 in complex with M1-F5L Heteromer
A0A075B6N1; A0A087WT01; A0A5B9; P04439; P61769;
1-89
Assess
The crystal structure of LC13 TcR in complex with HLAB8-EBV peptide complex Heteromer
P01850; P01889; P61769; Q3KST2;
1-89
Assess
The complex between TCR A6 and human Class I MHC HLA-A2 with the modified HTLV-1 TAX (Y5K-4-[3-Indo… Heteromer
P01850; P04439; P61769;
1-89
SO4; 13×GOL;3IB;
Assess
Structure of the HLA-E-VMAPRTLIL/KK50.4 TCR complex Heteromer
P01850; P13747; P16780; P61769;
1-89
IOD;
Assess
Crystal Structure of the LC13 TCR in complex with HLA B*4405 bound to EEYLKAWTF a mimotope Heteromer
P01850; P01889; P61769;
1-89
Assess
Crystal structure of the mCD1d/NC-aGC/iNKTCR ternary complex Heteromer
A0A0B4J1J9; A0A5B9; A2NTY6; P01887; P11609;
1-89
NAG;NAG;48G;NAG;
Assess
The complex between TCR A6 and human Class I MHC HLA-A2 with the bound HuD peptide Heteromer
P04439; P61769;
1-89
GOL;SO4;
Assess
The complex between TCR DMF5 and human Class I MHC HLA-A2 with the bound MART-1(26-35)(A27L) peptide Heteromer
P04439; P61769;
1-89
Assess
Crystal Structure of the LC13 TCR in complex with HLA B*4405 bound to EEYLQAFTY a self peptide from… Heteromer
P01850; P01889; P61769;
1-89
Assess
Recognition of Glycolipid Antigen by iNKT Cell TCR Heteromer
A0A5B9; P01887; P11609;
1-89
NAG;NAG;GSL;NAG;
Assess
Structure of the mouse CD1d-PyrC-alpha-GalCer-iNKT TCR complex Heteromer
P01887; P11609;
1-89
NAG;NAG;NAG;1LA;
Assess
CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A Heteromer
P04439; P61769;
1-89
Assess
Crystal structure of the public RA14 TCR in complex with the HCMV dominant NLV/HLA-A2 epitope Heteromer
P04439; P61769;
1-89
SO4;CL;
Assess
STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A Heteromer
P04439; P61769;
1-89
Assess
Recognition of a Glycolipid Antigen by the iNKT Cell TCR Heteromer
A0A5B9; P01887; P11609;
1-89
NAG;NAG;NAG;1O2;
Assess
Structural basis for recognition of mutant self by a tumor-specific, MHC class II-restricted TCR Heteromer
P01850; P01903; P01911; P60174;
1-89
Assess
Structure of the mouse CD1d-SMC124-iNKT TCR complex Heteromer
A0A5B9; P01887; P11609;
1-89
NAG;NAG;NAG;07P;GOL;
Assess
Structural Basis of Chronic Beryllium Disease: Bridging the Gap Between allergic hypersensitivity a… Heteromer
A0A5B9; P04440; P20036;
1-89
NAG;NA;0BE;
Assess
Crystal Structure of SB47 TCR-HLA B*3505-LPEP complex Heteromer
C5MK56; P01850; P61769; Q3KSS8;
1-89
NA;MG;
Assess
Structural basis for recognition of mutant self by a tumor-specific, MHC class II-restricted TCR Heteromer
P01850; P01903; P01911; P60174;
1-89
Assess
The complex between TCR A6 and human Class I MHC HLA-A2 with the modified HTLV-1 TAX (Y5(4-fluoroPh… Heteromer
P01850; P04439; P61769;
1-89
GOL;
Assess
T15-DQ8.5-glia-gamma1 complex Heteromer
A0A0B4J274; A0A0U5Q247; A0A580; A0A5B9; P01909; P08079;
1-89
NAG;NAG;
Assess
Crystal structure of the mCD1d/EF77/iNKTCR ternary complex Heteromer
A0A0B4J1J9; A0A5B9; A2NTY6; P01887; P11609;
1-89
NAG;NAG;49Y;
Assess
X-ray structure of the complex between staphylococcal enterotoxin B, T cell receptor and major hist… Heteromer
A0A5B9; P01552; P01903; P01911; P03437;
1-89
Assess
Structure of the mouse CD1d-alpha-C-GalCer-iNKT TCR complex Heteromer
A0A5B9; P01887; P11609;
1-89
NAG;NAG;QUX;
Assess
The complex among DMF5(alpha-D26Y, alpha-Y50A,beta-L98W) TCR, human Class I MHC HLA-A2 and MART-1(2… Heteromer
A0A075B6T6; A0A1B0GXE1; K7N5M4; P04439; P61769; Q16655;
1-89
Assess
Crystal Structure of DN6 TCR Heteromer
A0A5B9;
1-89
NAG;CL;GOL;
Assess
Crystal structure of the mCD1d/7DW8-5/iNKTCR ternary complex Heteromer
A0A0B4J1J9; A0A5B9; A2NTY6; P01887; P11609;
1-89
NAG;7DW;
Assess
Crystal structure of the mCD1d/GCK152/iNKTCR ternary complex Heteromer
A0A0B4J1J9; A0A5B9; A2NTY6; P01887; P11609;
1-89
NAG;NAG;49X;
Assess
Crystal Structure of SB27 TCR in complex with the 'restriction triad' mutant HLA-B*3508-13mer Heteromer
A0A5B9; P01889; P03206; P61769;
1-89
IOD;
Assess
Crystal structure of human autoreactive-Valpha24 NKT TCR in complex with CD1d-beta-galactosylcerami… Heteromer
P15813; P61769;
1-89
GCY;
Assess
Crystal structure of the mCD1d/GCK127/iNKTCR ternary complex Heteromer
A0A0B4J1J9; A0A5B9; A2NTY6; P01887; P11609;
1-89
NAG;NAG;49M;
Assess
Crystal structure of CD1d-lipid-antigen complexed with Beta-2-Microglobulin, NKT15 Alpha-Chain and … Heteromer
P15813; P61769;
1-89
NAG;NAG;AGH;
Assess
1E6 TCR in complex with HLA-A02 carrying YQFGPDFPIA Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P04439; P61769;
1-88
SO4;EDO;
Assess
A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell recept… Heteromer
A0A5B9;
1-88
ACY;
Assess
A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell recept… Heteromer
A0A5B9;
1-88
Assess
A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell recept… Heteromer
A0A5B9;
1-88
Assess
CD1a ternary complex with lysophosphatidylcholine and BK6 TCR Heteromer
P01850; P06126; P61769;
1-88
NAG;42H;
Assess
CD1a ternary complex with endogenous lipids and BK6 TCR Heteromer
P01850; P06126; P61769;
1-88
NAG;OLA;
Assess
human 199.16 TCR in complex with Melan-A/MART-1 (26-35) peptide and HLA-A2 Heteromer
A0A075B6N1; P04439; P61769; Q16655;
1-88
NA;
Assess
HLA Class I antigen Heteromer
A0A0B4J279; A0A592; A0A5B9; P04439; P40967; P61769;
1-87
10×EDO;GOL;SO4;
Assess
1E6 TCR in complex with HLA-A02 carrying RQFGPDFPTI Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P04439; P61769;
1-87
30×EDO;GOL;SO4;
Assess
Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a mela… Heteromer
P01850; P04439; P61769; Q16655;
1-87
EPE;SO4;
Assess
1E6 TCR in complex with HLA-A02 carrying MVW peptide Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P04439; P61769;
1-87
EDO;SO4;GOL;
Assess
HLA class I histocompatibility antigen Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P04439; P61769;
1-87
SO4;
Assess
Crystal structure of autoreactive-Valpha14-Vbeta6 NKT TCR in complex with CD1d-isoglobotrihexosylce… Heteromer
P01887; P11609;
1-87
NAG;NAG;LGN;
Assess
Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a mela… Heteromer
P01850; P04439; P61769;
1-87
SO4;GOL;
Assess
Crystal structure of autoreactive-Valpha14-Vbeta6 NKT TCR in complex with CD1d-beta-galactosylceram… Heteromer
P01887; P11609;
1-87
NAG;NAG;GCY;GOL;
Assess
The complex between TCR DMF4 and human Class I MHC HLA-A2 with the bound MART-1(26-35)(A27L) decame… Heteromer
P04439; P61769; Q16655;
1-87
Assess
The M33 TCR p3M33l/H-2 Ld Complex Heteromer
A0A5B9; P01738; P01897; P04213;
1-87
Assess
Crystal structure of autoreactive-Valpha14-Vbeta6 NKT TCR in complex with CD1d-sulfatide Heteromer
P01887; P11609;
1-87
NAG;NAG;NAG;CIS;
Assess
Crystal structure of autoreactive-Valpha14-Vbeta6 NKT TCR in complex with CD1d-globotrihexosylceram… Heteromer
P01887; P11609;
1-87
NAG;NAG;3GB;
Assess
Crystal structure of the B1 TCR in complex with HLA-DP4-Ply Heteromer
P01850; P04440; P20036; Q04IN8;
1-87
NAG;NAG;
Assess
Crystal Structure of a Complex of a Human alpha/beta-T cell Receptor, Influenza HA Antigen Peptide,… Heteromer
P01850; P01903; P01911; P03437;
1-86
NAG;NAG;
Assess
Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a mela… Heteromer
P01850; P04439; P61769;
1-86
TAM; 11×SO4;
Assess
COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201 Heteromer
A0A0K0K1A5; A0A5B9; P04437; P04439; P14079; P61769;
1-86
Assess
The complex between TCR DMF4 and human Class I MHC HLA-A2 with the bound MART-1(27-35) nonameric pe… Heteromer
P04439; P61769; Q16655;
1-86
Assess
42F3 TCR pCPC5/H-2Ld Complex Heteromer
A0A0A6YX08; A0A0G2JFA3; A0A5B9; P01738; P01897;
1-86
Assess
CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE,… Heteromer
P01850; P01903; P01911; P03437;
1-86
NAG;
Assess
Crystal structure of a human autoimmune TCR MS2-3C8 bound to MHC class II self-ligand MBP/HLA-DR4 Heteromer
A0A5B9; P01903; P01911;
1-86
Assess
Crystal structure of autoreactive-Valpha14-Vbeta6 NKT TCR in complex with CD1d-beta-lactosylceramide Heteromer
P01887; P11609;
1-86
NAG;NAG;3GD;
Assess
42F3 TCR pCPA12/H-2Ld complex Heteromer
A0A0A6YX08; A0A0G2JFA3; A0A5B9; P01738; P01897;
1-86
Assess
42F3 pCPB7/H-2Ld Complex Heteromer
A0A0A6YX08; A0A0G2JFA3; A0A5B9; P01738; P01897;
1-86
Assess
Crystal structure of a complete ternary complex of T cell receptor, peptide-MHC and CD4 Heteromer
A0A5B9; P01730; P01903; P01911;
1-86
Assess
Crystal Structure of the JM22 TCR in complex with HLA-A*0201 in complex with M1-G4E Heteromer
A0A075B6N1; A0A087WT01; A0A5B9; P04439; P61769;
1-85
Assess
Germline-governed recognition of a cancer epitope by an immunodominant human T cell receptor Heteromer
P01850; P61769; Q16655; Q8WLS4;
1-85
GOL;SO4;
Assess
Crystal structure of 3A6 TCR bound to MBP/HLA-DR2a Heteromer
P01850; P01903; P02686; Q30154;
3-86
Assess
Bel602-DQ8.5-glia-gamma1 complex Heteromer
A0A0B4J274; A0A0U5Q247; A0A580; A0A5B9; P01909; P08079;
1-83
NAG;CA;
Assess
42F3 TCR pCPE3/H-2Ld complex Heteromer
A0A0A6YX08; A0A0G2JFA3; A0A5B9; P01738; P01897;
1-83
Assess
MAGE-A3 Reactive TCR in complex with Titin Epitope in HLA-A1 Heteromer
A0A0B4J279; A0A578; A0A5B9; P04439; P61769; Q8WZ42;
1-82
GOL; 11×SO4;
Assess
Bel502-DQ8-glia-alpha1 complex Heteromer
A0A0B4J274; A0A0U5Q247; A0A580; A0A5B9; L8E864; P18573;
1-82
NAG;CA;
Assess
1E6 TCR in Complex with HLA-A02 carrying AQWGPDPAAA Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01308; P04439; P61769;
1-82
Assess
MAGE-A3 reactive TCR in complex with MAGE-A3 in HLA-A1 Heteromer
A0A0B4J279; A0A578; A0A5B9; P04439; P43357; P61769;
2-82
SO4;
Assess
UL40:01 TCR in complex with HLA-E with a non-natural amino acid Heteromer
A0A087WT03; A0A087X096; A0A0B4J200; A0A5B0; A0A5B9; P13747; P61769;
1-80
Assess
Crystal Structures of High Affinity Human T-Cell Receptors Bound to pMHC RevealNative Diagonal Bind… Heteromer
P04439; P61769; P78358;
1-79
SO4;PGE;7PE; 11×GOL;
Assess
1E6 TCR in Complex with HLA-A0e carrying RQWGPDPAAV Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P04439; P61769;
1-79
12×EDO;GOL;SO4;
Assess
Crystal Structures of High Affinity Human T-Cell Receptors Bound to pMHC Reveal Native Diagonal Bin… Heteromer
P04439; P61769; P78358;
1-78
GOL;MG;SO4;IPA;EPE;
Assess
T cell receptor CO3 Heteromer
A0A0C4DH28; A0A1B0GX56; P01850;
1-78
EDO;SO4;
Assess
Structure and binding kinetics of three different human CD1d-alpha- Galactosylceramide-specific T c… Heteromer
P01850;
1-78
Assess
Structure and binding kinetics of three different human CD1d-alpha- Galactosylceramide-specific T c… Heteromer
P01850;
1-78
Assess
Crystal Structure of clone42 TCR Heteromer
P01850;
1-77
Assess
Directed Evolution of Human T-cell Receptor CDR2 residues by phage display dramatically enhances af… Heteromer
P04439; P61769; P78358;
1-77
NA;GOL;
Assess
Crystal structures of high affinity human T-cell receptors bound to pMHC reveal native diagonal bin… Heteromer
P04439; P61769; P78358;
1-77
SO4; 11×GOL;CA;MG;EPE;
Assess
Crystal structure of staphylococcal enterotoxin E in complex with a T cell receptor Heteromer
A0A0B4J277; A0A5A3; A0A5B9; P12993;
1-77
ZN;NA;
Assess
Crystal structure of ELS4 TCR bound to HLA-B*3501 presenting EBV peptide EPLPQGQLTAY at 1.7A Heteromer
P01850; P01889; P03206; P61769;
1-77
Assess
CD1a-dideoxymycobactin-gdTCR complex Heteromer
A0A0C4DH28; A0A1B0GX56; P01850; P06126; P61769;
1-77
EDO;WGR;SO4;
Assess
Crystal structure of human TCR Alpha Chain-TRAV12-3, Beta Chain-TRBV6-5, Antigen-presenting molecul… Heteromer
A0A0B4J271; A0A0K0K1A5; A0A5B9; P15813; P61769;
1-77
NAG;JLS;
Assess
Crystal structure of the B5 TCR in complex with HLA-DP4-Ply Heteromer
P01850; P04440; P20036; Q04IN8;
1-75
NAG;EDO;NAG;
Assess
CD1a-sulfatide-gdTCR complex Heteromer
A0A0C4DH28; A0A1B0GX56; P01850; P06126; P61769;
1-65
CIS;EDO;NAG;PEG;SO4;
Assess
CD1a-endo-gdTCR complex Heteromer
A0A0C4DH28; A0A1B0GX56; P01850; P06126; P61769;
1-62
PEG;SO4;
Assess
COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201 Heteromer
A0A075B6T6; A0A0K0K1A5; A0A5B9; P04439; P14079; P61769;
1-4
EMC;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7phr.1.Amonomer0.651-140
100.00
Assess
6mf8.1.Amonomer0.5696-140
86.67
Assess